Characterization of mutation spectra with ultra-deep pyrosequencing: Application to HIV-1 drug resistance GENOME RESEARCH Wang, C., Mitsuya, Y., Gharizadeh, B., Ronaghi, M., Shafer, R. W. 2007; 17 (8): 1195-1201


The detection of mutant spectra within a population of microorganisms is critical for the management of drug-resistant infections. We performed ultra-deep pyrosequencing to detect minor sequence variants in HIV-1 protease and reverse transcriptase (RT) genes from clinical plasma samples. We estimated empirical error rates from four HIV-1 plasmid clones and used them to develop a statistical approach to distinguish authentic minor variants from sequencing errors in eight clinical samples. Ultra-deep pyrosequencing detected an average of 58 variants per sample compared with an average of eight variants per sample detected by conventional direct-PCR dideoxynucleotide sequencing. In the clinical sample with the largest number of minor sequence variants, all 60 variants present in > or =3% of genomes and 20 of 35 variants present in <3% of genomes were confirmed by limiting dilution sequencing. With appropriate analysis, ultra-deep pyrosequencing is a promising method for characterizing genetic diversity and detecting minor yet clinically relevant variants in biological samples with complex genetic populations.

View details for DOI 10.1101/gr.6468307

View details for Web of Science ID 000248491800008

View details for PubMedID 17600086

View details for PubMedCentralID PMC1933516